ArticleScience advances2025
Integrated horizontal convective PCR system for clinical diagnostics.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid and accurate disease diagnosis in resource-limited settings is critical for optimizing medical resources and controlling epidemic outbreaks. However, developing a point-of-care detection system that is user-friendly, cost-effective, highly accurate, and exhibits strong specificity remains a formidable challenge. Here, we report an integrated horizontal convection PCR system (IHCS) for clinical point-of-care testing, capable of real-time fluorescence detection. IHCS leverages horizontal thermal convection within a capillary to drive sample flow and temperature cycling for nucleic acid amplification, making it suitable for both home use and on-site rapid detection. Capillary action enables swift sample loading, thereby simplifying the overall procedure, and the horizontal thermal convection overcomes the volume limitations inherent in vertical systems. Validation with 130 clinical samples demonstrated that the system successfully detected HBV, SARS-CoV-2, and influenza A virus within 40 min, achieving excellent sensitivity (>96%) and specificity (100%). Overall, the IHCS integrates microfluidics, thermal engineering, and optical sensing and offers a paradigm-shifting solution for point-of-care diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.